Evidence map›Paper›PMID 31664168›Full record

ArticleScientific reports2019

Lipidomic signatures of aortic media from patients with atherosclerotic and nonatherosclerotic aneurysms.

Kosuke Saito, Hiroaki Yagi, Keiko Maekawa, Mitsuhiro Nishigori, Masaki Ishikawa, Sayaka Muto, Tsukasa Osaki, Yutaka Iba, Kenji Minatoya, Yoshihiko Ikeda and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Lipidomic insights on abdominal aortic aneurysm and peripheral arterial disease.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Kosuke SaitoDivision of Medical Safety Science, National Institute of Health Sciences, Kanagawa, Japan.
Hiroaki YagiDepartment of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
Keiko MaekawaDivision of Medical Safety Science, National Institute of Health Sciences, Kanagawa, Japan.
Mitsuhiro NishigoriDepartment of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
Masaki IshikawaDivision of Medical Safety Science, National Institute of Health Sciences, Kanagawa, Japan.
Sayaka MutoDepartment of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Tsukasa OsakiDepartment of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
Yutaka IbaDepartment of Vascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kenji MinatoyaDepartment of Vascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
Yoshihiko IkedaDepartment of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Hatsue Ishibashi-UedaDepartment of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Hitoshi OginoDepartment of Vascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
Hiroaki SasakiDepartment of Vascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
Hitoshi MatsudaDepartment of Vascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
Yoshiro SaitoDivision of Medical Safety Science, National Institute of Health Sciences, Kanagawa, Japan. yoshiro@nihs.go.jp.
Naoto MinaminoDepartment of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. minamino@ncvc.go.jp.
National Cerebral and Cardiovascular Center · JPNational Institute of Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic aneurysms are associated with fatal aortic rupture. Current therapeutic approaches are limited to implantation of aortic prostheses and stent-grafts; no effective drugs are available because the pathogenic mechanisms of aortic aneurysms remain unclear. Here, we aimed to elucidate the molecular mechanisms of the initiation and progression of aortic aneurysm by lipidomics. We performed lipidomics analyses of lipids in the aortic media of normal, border, and aneurysm areas from patients with thoracic atherosclerotic aortic aneurysm (N = 30), thoracic nonatherosclerotic aortic aneurysm (N = 19), and abdominal atherosclerotic aortic aneurysm (N = 11) and from controls (N = 8) using liquid chromatography and mass spectrometry. Significant alterations were observed in the lipid profiles of patients with atherosclerotic aortic aneurysms and to a lesser extent in those with nonatherosclerotic aneurysms. Increased triacylglycerols (TGs) and decreased ether-type phosphatidylethanolamines (ePEs) were observed throughout the normal, border, and aneurysm areas of thoracic and abdominal atherosclerotic aortic aneurysms. Prostaglandin D

Indexed as

LipidomicsAdultAgedAneurysmAortaAtherosclerosisFemaleHumansMaleMiddle AgedRisk FactorsTunica Media

Identifiers

PMID31664168
PMCPMC6820727
OpenAlexW2982310222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.